Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2970966 | The Journal of Heart and Lung Transplantation | 2010 | 9 Pages |
Abstract
First-line epoprostenol treatment may lead to greater improvement in exercise capacity than first-line bosentan. However, these greater exercise improvements did not translate into longer time to disease progression or survival.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Wouter MD, Anco MD, PhD, Monika Brand, Daniel M. PhD, Berthold MSc, Pieter E. MD, PhD, Anton MD, PhD,